About the Company
We do not have any company description for Quince Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Quince Therapeutics, Inc.
Quince, Niagen, Intrabio busy in rare A-T disease
Quince Therapeutics Inc.’s mid-July completion of enrollment in the pivotal phase III study in ataxia-telangiectasia (A-T) ...
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes EryDex ...
Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...
Quince Therapeutics Inc News (QNCX) - Investing.com
Quince Therapeutics stock initiated with Market Outperform rating at JMP Investing.com - Quince Therapeutics Inc. (NASDAQ:QNCX), a biotech company whose shares have surged over 130% in the past ...
Quince Therapeutics, Inc.: Quince Therapeutics to Participate at A-T ...
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced its ...
Quince Therapeutics to Participate at A-T Society’s 2025 A-T Clinical ...
Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases.
Quince Therapeutics Completes Acquisition of EryDel S.p.A.
Quince Therapeutics, Inc., a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’ s own biology to deliver rare disease therapeutics ...
Quince Therapeutics Details Strategic Growth Plan with Launch ... - Nasdaq
Quince Therapeutics, Inc., a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, provided an overview of its strategic growth plan in ...
Quince Therapeutics, Inc. (QNCX) - Yahoo Finance
Get the detailed quarterly/annual income statement for Quince Therapeutics, Inc. (QNCX). Find out the revenue, expenses and profit or loss over the last fiscal year.
Quince Therapeutics Announces Closing of Up to $22 Million Private ...
About Quince Therapeutics Quince Therapeutics, Inc. is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases.
What's Going On With Quince Therapeutics Stock Today
Quince Therapeutics Inc QNCX has agreed to acquire EryDel SpA, a privately-held, late-stage biotech company, in a stock-for-stock upfront exchange and potential downstream milestone cash payments ...
QNCX - Quince Therapeutics Inc News | Morningstar
Quince Therapeutics Inc QNCX Stock XNAS Rating as of Aug 1, 2025 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Key Metrics Financials Valuation Dividends Ownership Executive ...
Similar Companies
Loading the latest forecasts...